Medizinische Universität Graz - Research portal
Navigation/Search
- Researchers
- Institutions
- Projects
- Publications
- Partners
- Sponsors
- Equipment
- Knowhow
- Fields of Research
"Faces" of the day:
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Weitzer, F; Nazerani-Hooshmand, T; Aigner, RM; Pernthaler, B.
Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Clin Nucl Med. 2021; 46(7): e358-e359-e358-e359.
Doi: 10.1097/RLU.0000000000003538
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Weitzer Friedrich
- Co-authors Med Uni Graz
- Aigner Reingard
- Nazerani-Zemann Tina
- Pernthaler Birgit
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Prostate-specific membrane antigen (PSMA) overexpression has been described in various malignancies. Hereby we present a case of a 69-year-old man simultaneously diagnosed with prostate cancer, esophageal adenocarcinoma, and HCC (hepatocellular carcinoma). 18F-FDG PET/CT showed pathological uptake in the esophageal adenocarcinoma and the primary prostate tumor, whereas 68Ga-PSMA-11 PET/CT performed for staging of the histopathologically confirmed prostate cancer revealed the primary tumor and significant uptake in the HCC. This finding is remarkable because the high physiological liver uptake of 68Ga-PSMA-11 may hamper the detection of small lesions. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
- Find related publications in this database (Keywords)
- Ga-68-PSMA PET/CT
- F-18-FDG PET/CT
- hepatocellular carcinoma
- prostate cancer
- esophageal carcinoma